Malaria Journal

official impact factor 3.49

This article is part of the supplement: Building Knowledge for Action: Proceedings of the 5th Multilateral Initiative on Malaria Pan-African Malaria Conference

Open Access Highly Access

Is vaccine the magic bullet for malaria elimination? A reality check

Roma Chilengi* and Jesse Gitaka

Malaria Journal 2010, 9(Suppl 3):S1 doi:10.1186/1475-2875-9-S3-S1

Accesses  

  • Last 30 days: 149 accesses
  • Last 365 days: 2048 accesses
  • All time: 3911 accesses

Cited by

BioMed Central: 3 citations

Research   Open Access

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya

Raymond K Sudoi, Sophie Githinji, Andrew Nyandigisi, Alex Muturi, Robert W Snow, Dejan Zurovac Malaria Journal 2012, 11:37 (8 February 2012)

A paper which helps to understand how supply is organized from central to peripheral level, and how this might affect the supply of peripheral units.

Research   Open Access Highly Accessed

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries

Kathryn A O'Connell, Hellen Gatakaa, Stephen Poyer, Julius Njogu, Illah Evance, Erik Munroe, Tsione Solomon, Catherine Goodman, Kara Hanson, Cyprien Zinsou, Louis Akulayi, Jacky Raharinjatovo, Ekundayo Arogundade, Peter Buyungo, Felton Mpasela, Chérifatou Adjibabi, Jean Agbango, Benjamin Ramarosandratana, Babajide Coker, Denis Rubahika, Busiku Hamainza, Steven Chapman, Tanya Shewchuk, Desmond Chavasse Malaria Journal 2011, 10:326 (31 October 2011)

This article is part of a collection on The ACTwatch project:...

Useful synthesis of survey results providing essential information on the availability of anti-malarials, especially in the private sector where data has been extremely limited.

Research   Open Access

Discovery of potent, novel, non-toxic anti-malarial compounds via quantum modelling, virtual screening and in vitro experimental validation

David J Sullivan, Nikola Kaludov, Martin N Martinov Malaria Journal 2011, 10:274 (20 September 2011)

The gradient metric modelling approach and electron-density molecular representation can be powerful tools in the discovery and design of novel anti-malarial compounds. The technology can be used for de novo design of small molecules with activity against not only the asexual phase, but also against the liver stage of the parasite.